Chronic HCV infection is a global health problem that affects> 184 million people worldwide.
HCV is associated with several hepatic and extrahepatic disorders, including several …

Worldwide, more than one million people die each year from hepatitis C virus (HCV) related
diseases, and over 300 million people are chronically infected with hepatitis B or C. Egypt …

The burden of liver disease may dramatically increase in the near future in Africa, where
screening and access to care and treatment are hampered by inadequate disease …

Hepatocellular carcinoma (HCC) is the sixth most common primary malignancy worldwide,
and the third most common cause of death among cancers worldwide. HCC occurs in …

Background Egypt has one of the highest prevalences and burdens of hepatitis C virus
(HCV) worldwide, and a large government treatment programme. However, identifying and …

Conclusions Mass spectrometric analysis identified serine 335 in the SDS1 region of mNrf2
as the major phosphorylation site for modulation of Nrf2 ubiquitylation by P‐JNK. This study …

Hepatitis C virus (HCV) genotype (GT) 4 represents 12%-15%(15-18 million) of total global
HCV infection. It is prevalent in Northern and Equatorial Africa and the Middle East, and is …

Objective To identify current risk factors for hepatitis C virus (HCV) acquisition among E
gyptians. Methods Patients with acute HCV were identified through a surveillance system of …

Abstract Introduction Viral hepatitis C (HCV) and B (HBV) were at the top of Egypt's most
significant public health challenges, with an estimated 14.7% of its population having …

Abstract Background & Aims The prevention and control of HCV infection is complex and
challenging in terms of describing risk factors and modes of transmission. This meta …